CONSTITUTIONAL PROPORTIONALITY IN BIOTECHNOLOGY REGULATION

1. INTRODUCTION

The constitutional proportionality test is a judicial standard used to determine whether restrictions imposed by the State on fundamental rights are justified by legitimate public objectives. In biotechnology, it is particularly important because government regulation must balance public health, biosafety, biosecurity, environmental protection, scientific freedom, privacy, and individual autonomy.

Restrictions on gene editing, genetic testing, human embryo research, clinical trials, genomic databases, reproductive technologies, and genetically modified organisms may be necessary to prevent serious harm. However, an absolute prohibition or excessive regulatory interference may violate constitutional rights if less restrictive measures could achieve the same protective purpose.

In India, proportionality is principally developed through Articles 14, 19, and 21 of the Constitution. Although Indian courts have not established a single proportionality doctrine exclusively for biotechnology, constitutional precedents provide a framework for assessing the legality and justification of biotech restrictions.

2. CONSTITUTIONAL AND LEGAL FRAMEWORK

A. ARTICLE 14: EQUALITY AND NON-ARBITRARINESS

Article 14 prohibits arbitrary State action and requires legally defensible distinctions. Biotechnology restrictions must therefore rest on rational criteria, such as demonstrated risk, the nature of the biological material, potential environmental effects, and the severity of possible harm.

For example, imposing identical restrictions on low-risk diagnostic testing and high-risk experimental pathogen engineering may be challenged if the regulatory distinction between activities is irrational or the restrictions are inadequately justified.

B. ARTICLE 19: FREEDOM OF SCIENTIFIC EXPRESSION AND OCCUPATION

Article 19(1)(a) protects freedom of speech and expression, while Article 19(1)(g) protects the right to practise a profession or carry on an occupation, trade, or business. These rights may be relevant to scientific publication, research activities, biotechnology enterprises, and laboratory operations.

Restrictions must satisfy the applicable constitutional requirements, including the relevant grounds for reasonable restrictions under Articles 19(2) and 19(6). Public health and safety concerns may justify regulation, but restrictions must remain within constitutional limits.

C. ARTICLE 21: LIFE, DIGNITY, PRIVACY, AND AUTONOMY

Article 21 protects life and personal liberty, including privacy, dignity, and decisional autonomy. These protections are significant when biotechnology involves genetic information, reproductive choices, experimental treatment, or human biological samples.

The State must establish lawful authority for rights-infringing measures and justify interference through legitimate objectives and proportionate means. Consent, confidentiality, scientific validity, and independent ethical review may be important safeguards.

3. THE FOUR-STAGE PROPORTIONALITY TEST

The Supreme Court's jurisprudence, particularly Modern Dental College and K.S. Puttaswamy, supports a structured assessment of rights restrictions.

FIRST: LEGITIMATE AIM

The State must identify a constitutionally legitimate objective, such as preventing biological hazards, protecting research participants, preventing disease transmission, or safeguarding the environment.

SECOND: RATIONAL CONNECTION

The restriction must have a rational connection with the stated objective. For instance, requiring additional containment measures for high-risk biological experiments may be justified where evidence supports their effectiveness.

THIRD: NECESSITY AND LESS RESTRICTIVE ALTERNATIVES

The court considers whether a less restrictive but sufficiently effective alternative is available. Alternatives may include risk-based licensing, independent ethics review, enhanced containment, informed consent, monitoring, or targeted restrictions instead of a complete ban.

FOURTH: BALANCING

The court weighs the benefits of the restriction against its adverse effects on fundamental rights. The greater the interference with autonomy, privacy, research, or occupation, the stronger the justification and safeguards generally required.

The precise intensity of review depends on the constitutional right involved, the statutory framework, and the nature of the restriction.

4. RELEVANT CASE LAWS

1. Modern Dental College and Research Centre v. State of Madhya Pradesh (2016), (2016) 7 SCC 353 — DIRECT AUTHORITY ON PROPORTIONALITY

The Supreme Court applied proportionality while examining State regulation of private professional educational institutions. The judgment explains that restrictions must pursue a proper purpose and bear a rational relationship to that purpose, with necessity also relevant.

Application: Its principles can be applied by analogy to biotechnology licensing, laboratory accreditation, and professional restrictions where regulatory measures interfere with constitutionally protected freedoms.

2. Justice K.S. Puttaswamy (Retd.) v. Union of India (2017), (2017) 10 SCC 1 — DIRECT AUTHORITY ON PRIVACY

A nine-judge Bench recognised privacy as a fundamental right protected by the Constitution. The judgment connected privacy with dignity, autonomy, and personal liberty.

Application: This is central to compulsory genetic testing, genomic databases, genetic surveillance, and disclosure of genetic information. Restrictions must be supported by law and justified under the applicable constitutional standards.

3. K.S. Puttaswamy v. Union of India (Aadhaar) (2019), (2019) 1 SCC 1 — DIRECT AUTHORITY ON DATA-RELATED PROPORTIONALITY

The Court considered privacy restrictions arising from the Aadhaar framework. The judgments addressed legitimate State objectives, proportionality, data protection, and safeguards, although the judges differed on aspects of the scheme.

Application: The reasoning is relevant to national genomic databases and compulsory genetic identification, particularly concerning necessity, data security, purpose limitation, and access restrictions.

4. Anuradha Bhasin v. Union of India (2020), (2020) 3 SCC 637 — DIRECT AUTHORITY ON RESTRICTIONS AFFECTING FUNDAMENTAL RIGHTS

The Supreme Court examined restrictions on internet access in Jammu and Kashmir and emphasised proportionality, publication of restriction orders, and judicial review.

Application: Its principles are relevant by analogy to restrictions on digital genomic research platforms, scientific communication, and access to research infrastructure.

5. Gujarat Mazdoor Sabha v. State of Gujarat (2020), (2020) 10 SCC 459 — DIRECT AUTHORITY ON EMERGENCY MEASURES AND PROPORTIONALITY

The Supreme Court invalidated Gujarat's blanket exemption of certain factories from statutory working-hour protections during the COVID-19 pandemic. The judgment scrutinised the justification for emergency measures and the need for safeguards against abuse.

Application: It supports careful scrutiny of sweeping emergency biotechnology restrictions, particularly where public-health objectives are invoked to justify extensive interference with legal protections.

6. Association for Molecular Pathology v. Myriad Genetics, Inc. (2013), 569 U.S. 576 — ANALOGOUS FOREIGN AUTHORITY

The United States Supreme Court held that naturally occurring DNA segments are not patentable merely because they have been isolated, while synthetically created complementary DNA may qualify for patent protection under the Court's reasoning.

Application: The decision illustrates the relationship between biological science, legal classification, and innovation. It is not an Indian constitutional proportionality ruling and does not directly establish a test for biotech restrictions.

5. PRACTICAL APPLICATION AND REGULATORY SAFEGUARDS

When designing or challenging biotechnology restrictions, authorities and affected institutions should:

Identify the statutory authority and precise constitutional objective.

Conduct evidence-based risk assessments appropriate to the technology.

Evaluate less restrictive regulatory alternatives.

Protect informed consent, confidentiality, and individual autonomy where applicable.

Provide reasons, review mechanisms, and independent oversight for significant restrictions.

Establish safeguards against arbitrary enforcement, discriminatory treatment, and excessive data collection.

6. CONCLUSION

The constitutional proportionality test ensures that biotechnology regulation does not become unnecessarily restrictive in the pursuit of legitimate public interests. In India, Modern Dental College, Puttaswamy, Anuradha Bhasin, and Gujarat Mazdoor Sabha provide significant judicial guidance. Their principles require lawful authority, a legitimate objective, a rational connection, consideration of less restrictive alternatives, and appropriate balancing of competing interests.

Ultimately, biotechnology restrictions are most defensible when they are evidence-based, risk-sensitive, transparent, and accompanied by effective safeguards. The objective is not to eliminate necessary regulation but to ensure that public protection and scientific governance remain consistent with constitutional rights.